Immunology and Microbiology
Systemic Lupus Erythematosus
100%
interferon
69%
Systemic Scleroderma
50%
Macrophage
50%
Neutrophil
35%
Fibroblast
34%
Granulomatosis with Polyangiitis
33%
Mitogen
33%
Hypoxia Inducible Factor 1
33%
Inflammatory Arthritis
32%
Cytokine
26%
Glycation
24%
Tumor Necrosis Factor Alpha
23%
Neutrophil Granulocyte
23%
Vasculotropin
21%
Upregulation
20%
Oxidative Stress
20%
Autoantibodies
20%
Protein Synthesis
16%
Staphylococcus Aureus
16%
Orthomyxoviridae
16%
Mucosal-Associated Invariant T Cell
16%
Hepatoma Cell
16%
Granulopoiesis
16%
Neutrophil Extracellular Traps
16%
Vasculitis
16%
Granulocyte
16%
Nephritis
16%
CD177
16%
Monocyte
16%
Interleukin 21
16%
B Lymphocyte Subpopulation
16%
T Cell
16%
Transcriptomics
16%
Acute Phase Protein
16%
Chemokine
16%
Cell Line
16%
Periodontitis
16%
Placenta
16%
Antiphospholipid Syndrome
16%
Interferon
14%
Mediator
14%
B Cell
13%
Lupus Erythematosus
12%
Interleukin 17
12%
Superantigen
11%
ELISA
11%
Raynaud Phenomenon
10%
ANCA Associated Vasculitis
10%
Serum Amyloid A
9%
Keyphrases
Free Thiols
35%
Systemic Lupus Erythematosus Patient
33%
Systemic Lupus Erythematosus
27%
Lupus Nephritis
25%
Oxidative Stress
24%
Macrophages
22%
Dutch
19%
Systemic Oxidative Stress
18%
Interferon Score
16%
Myxovirus Resistance Protein A
16%
Clinical Transcriptomics
16%
IgG Antibody Titer
16%
Monocyte-derived Macrophages
16%
Strong Inhibition
16%
Interleukin-8
16%
Human Hepatoma Cells
16%
COVID-19
16%
Nephritis
16%
Cyclooxygenase-2
16%
Cross-sectional Clinical Study
16%
Continuous Renal Replacement Therapy
16%
IFN Score
16%
Toxic Shock Syndrome toxin-1 (TSST-1)
16%
Streptococcal Toxic Shock Syndrome
16%
P38 Mitogen-activated Protein Kinase Inhibitor
16%
Intensivist
16%
Neutrophil Adhesion
16%
MRNA Expression
16%
Neutrophil Subsets
16%
Kidney Transplant Recipients
16%
Tumor Necrosis Factor-α
16%
Intensive Care
16%
Oxidative Stress Markers
16%
Healthcare Network
16%
Placenta
16%
Interferon-α (IFN-α)
16%
Antiphospholipid Syndrome
16%
Disease Syndrome
16%
Neutrophil Extracellular Traps
16%
Renal Involvement
16%
Healthy Controls
12%
Serum-free
11%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
11%
Inflammatory Mediators
11%
Trust Level
10%
CaMKII Inhibitor
10%
Thiol Levels
9%
SLE Disease Activity Index (SLEDAI)
8%
SARS-CoV-2 Vaccination
8%
Non-rheumatoid
6%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
37%
Rheumatoid Arthritis
34%
Hypoxia Inducible Factor 1
33%
Wegener Granulomatosis
33%
Systemic Sclerosis
33%
Mitogen Activated Protein Kinase P38
27%
Cytokine
23%
Biological Marker
23%
Inflammation
23%
Interstitial Lung Disease
23%
Tumor Necrosis Factor
22%
Mitogen Activated Protein Kinase P38 Inhibitor
21%
Advanced Glycation End Product Receptor
20%
Chemokine
16%
Systemic Lupus Erythematosus
16%
Nephritis
16%
Toxic Shock Syndrome Toxin 1
16%
Liver Cell Carcinoma
16%
Acute Phase Protein
16%
Staphylococcus Aureus
16%
Disease
16%
Pharmacokinetics
16%
Cefotaxime
16%
Pulmonary Hypertension
16%
Interleukin 1beta
12%
Serum Amyloid A
11%
C Reactive Protein
11%
Lupus Erythematosus Nephritis
11%
Superantigen
11%
Disease Activity
9%
Hypoxia
7%
Gelatinase B
7%
Fibrinogen
7%
Protein
6%
Transcription Factors
5%
